SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Vadim D. Marchenko who wrote (175)11/20/1996 6:26:00 PM
From: scaram(o)uche   of 2742
 
Good. This is very different than anything that I've seen before. Let's work with it.

Message from Vadim D. Marchenko on Nov 20 1996 4:33PM EST

Buying CIST as a "Cash Cow" ? I just did some quick and dirty calculations,
making the following assumptions which intended to make conservative : 1. CIST is
getting $12m as their share of settlement over the next 4 years, PV @ 7% =
$11.22m
*************************
OK, can't get more conservative than that. I hope.
**************************

2. Immunex settled for 3 x what the patents are worth ( in other words
assuming the patents are worth $7m ).
*************************
Interesting. This obviously didn't come from thin air. Is this 3X used as a standard in some sector?
**************************

3. Stuff compensation =5 people x 80
hrs/week x 52 weeks @ $200/hr = 4.16m +$.84m for insignificant other = $5m.
****************************
You lost me here. Are you taking out four years of operating expenses?
*******************************
4.Taxes = .35 x ( 11.22 + 7 - 5 ) = $4.62m
******************************
Some are assuming that the settlement will not be taxed. I don't know enough to comment. Bob?
*******************************

5. Adding up the above = $8.6m or
roughly $.31 a share. PLUS you get the rest of the company for free, including all
other patents AND the name of the company that owns these patents, the very one
that forced Immunex to settle out of court. IMHO it is worth some extra.
*****************************
I think this is the point that I feel strongly about, obviously. I feel that the existing business could be made to hum in short order. I did a medline on the inventor for the recent assay (IL-1beta in biological specimens) patent, and it looks like he may have moved on to Ortho. Not certain about that. The 10-K says that they have a senior scientist. Anyone know who it is?
******************************************

Buying
CIST @ $.30 a share looks like a good deal to me even if you totally discount the
abilities of the management ( was quoted as being "brilliant" before) and turn around
and sell off the pieces. The bottom line is I do not see how it could be valued below
$.3. Any thoughts ?
*************************************

Vadim......... OK, so you're saying forget about CIST's products, properties and license agreements, assume worst case is a bunch of clowns just babysitting the settlement for four years? Or am I lost?
Interesting. Thanks.

Rick
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext